1型糖尿病患者骨质疏松的患病率及危险因素:一项观察性研究结果
在丹麦Steno糖尿病中心Aarhus大学医院1型糖尿病门诊,2020-2022年对764例1型糖尿病患者行腰椎和髋部DXA筛查,25.5%符合WHO骨质疏松标准(椎体骨折或T值≤-2.5),36%符合ADA治疗标准(椎体骨折或T值≤-2.0)。多变量分析显示年龄增加和骨质疏松家族史与骨质疏松风险升高相关,BMI增加与风险降低相关。作者提出对绝经后女性和年龄>50岁男性1型糖尿病患者筛查骨质疏松。
要点
- 764例1型糖尿病患者中25.5%符合WHO骨质疏松标准,36%符合ADA治疗标准。
- 年龄增加(OR=1.3,95%CI 1.0;1.7)和骨质疏松家族史(OR=1.9,95%CI 1.2;3.0)与骨质疏松风险升高相关。
- BMI增加与骨质疏松风险降低相关(OR=0.87,95%CI 0.82;0.92)。
核心结论
- 本研究发现高比例的1型糖尿病患者患有骨质疏松,更高比例符合ADA提出的治疗标准,因此早期发现和治疗骨质疏松可能降低1型糖尿病中明显增加的骨折风险。
研究设计与样本
- 横断面研究,数据来自丹麦Aarhus大学医院Steno糖尿病中心1型糖尿病门诊,2020-2022年期间对在诊活跃随访者提供腰椎和髋部DXA筛查。
主要发现
- 共764例1型糖尿病患者接受DXA,其中25.5%基于椎体骨折或T值≤-2.5诊断为骨质疏松。
- 36%符合ADA治疗标准(椎体骨折或T值≤-2.0)。
- 多变量分析中,年龄增加与骨质疏松风险升高相关(OR=1.3,95%CI 1.0;1.7)。
- 骨质疏松家族史与骨质疏松风险升高相关(OR=1.9,95%CI 1.2;3.0)。
- BMI增加与骨质疏松风险降低相关(OR=0.87,95%CI 0.82;0.92)。
关键数值与推荐
- 骨质疏松诊断采用WHO经典标准:椎体骨折或T值≤-2.5。
- ADA提出的治疗标准为椎体骨折或T值≤-2.0。
临床怎么用
- 作者提出对绝经后女性和年龄>50岁的男性1型糖尿病患者进行骨质疏松筛查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The prevalence of osteoporosis in individuals with type 1 diabetes (T1D) was investigated. Based on IOF/ADA recommendations, 36% had indications for anti-osteoporotic therapy. We propose that postmenopausal women and men with T1D and age > 50 years are screened for osteoporosis. PURPOSE: Type 1 diabetes is associated with an increased fracture risk and a lowering of the threshold for osteoporosis treatment has been recommended to be increased from a bone mineral density of a T-score ≤ - 2.5 to a T-score ≤ - 2.0. In this study, we aimed to investigate the prevalence and risk factors for osteoporosis in type 1 diabetes using the classic diagnostic criteria defined by WHO and the novel T-score cutoff of - 2.0 proposed by the ADA. METHODS: In a cross-sectional study, data were collected from the type 1 diabetes clinic at Steno Diabetes Center Aarhus, Aarhus University Hospital, where active attenders in the clinic were offered screening for osteoporosis using DXA of the lumbar spine and hip in the time period 2020-2022. RESULTS: A total of 764 individuals with type 1 diabetes had a DXA and of these, 25.5% had osteoporosis based on a vertebral fracture or T-score ≤ - 2.5, and 36% met ADA-treatment criteria with a vertebral fracture or T-score ≤ - 2.0. In multivariate analysis increasing age (OR = 1.3, 95% CI 1.0; 1.7) and a family history of osteoporosis (OR = 1.9, 95% CI 1.2; 3.0) were associated with an increased risk of osteoporosis, whereas an increase in BMI was associated with a decreased risk of osteoporosis (OR = 0.87, 95% CI 0.82; 0.92). CONCLUSION: The present study finds that a high proportion of individuals with type 1 diabetes have osteoporosis, and an even higher proportion meet the treatment criteria proposed by the ADA, and thus, early detection and treatment of osteoporosis may reduce the apparent increased fracture risk in type 1 diabetes.
引用
- Starup-Linde J, Støy J, Grinderslev PB, et al. Prevalence and risk factors for osteoporosis in type 1 diabetes-results from an observational study. Osteoporos Int. 2025. PMID: 40100348. doi:10.1007/s00198-025-07443-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。